Pathway enrichment analysis suggests that LURAP1L-AS1 may function as a competing endogenous RNA (ceRNA), sequestering tumor-suppressive miRNAs such as miR-7a-5p, miR-101-3p, miR-181a-5p, and miR-27a-3p. This evidence concerns the gene LURAP1L and neoplasm.